Steroid psychosis: A review for neurosurgeons

Journal of Neuro-Oncology

Volumn 109, Issue 3, 2012, Pages 439-447

  Ross, Donald A ^a,b   Cetas, Justin S ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Dexamethasone; Neurosurgery; Psychosis; Side effects; Steroids

Indexed keywords

AMITRIPTYLINE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CORTICOSTEROID; CORTICOTROPIN; DEXAMETHASONE; FLUOXETINE; GABAPENTIN; GLUCOCORTICOID; HALOPERIDOL; IMIPRAMINE; KETOCONAZOLE; LAMOTRIGINE; LITHIUM; METYRAPONE; MIFEPRISTONE; NEUROLEPTIC AGENT; OLANZAPINE; PHENOTHIAZINE DERIVATIVE; PREDNISONE; QUETIAPINE; RISPERIDONE; SERTRALINE; STEROID; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

AGGRESSION; AMYGDALOID NUCLEUS; ANXIETY; ASTHMA; ATAXIA; ATTENTION DISTURBANCE; BIPOLAR DISORDER; BLURRED VISION; COGNITIVE DEFECT; CONCENTRATION LOSS; CONFUSION; CUSHING SYNDROME; DELIRIUM; DEMENTIA; DENDRITIC SPINE; DEPRESSION; DISEASE SEVERITY; DISORIENTATION; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG WITHDRAWAL; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; HIPPOCAMPUS; HUMAN; HYPOMANIA; INSOMNIA; IRRITABILITY; MANIA; MEMORY DISORDER; MENTAL DISEASE; MENTAL INSTABILITY; MOOD DISORDER; MULTIPLE SCLEROSIS; NEOCORTEX; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; PERSEVERATION; PERSONALITY; PSYCHOSIS; REVIEW; SIDE EFFECT; SODIUM BLOOD LEVEL; STEROIDOGENESIS; SUICIDAL IDEATION; TREMOR;

ADRENAL CORTEX HORMONES; HUMANS; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 84866043421     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0919-z     Document Type: Review

References (133)

1. UpToDate (2012) Major side effects associated with glucocorticoid therapy. http://www.uptodate.com/contents/major-sideeffectsof-systemic- glucocorticoids. Accessed 24 Apr. 2012
2. Hawryluk G W J, Rowland J, Kwon BK, Fehlings MG (2008) Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury. Neurosurg Focus 25:E14
3. Sughrue ME, Shah JK, Devin JK, Kunwar S, Blevins LS Jr (2010) Utility of the immediate postoperative cortisol concentrations in patients with Cushing's disease. Neurosurgery 67:688-695 (discussion 695)
4. Rabinstein AA, Bruder N (2011) Management of hyponatremia and volume contraction. Neurocrit Care 15:354-360
5. Wittich CM, Ficalora RD, Mason TG, Beckman TJ (2009) Musculoskeletal injection. Mayo Clin Proc 84:831-836 (quiz 837)
6. Warrington TP, Bostwick JM (2006) Psychiatric adverse effects of corticosteroids. Mayo Clin Proc 81:1361-1367 (Pubitemid 44484975)
7. Travlos A, Hirsch G (1993) Steroid psychosis: a cause of confusion on the acute spinal cord injury unit. Arch Phys Med Rehabil 74:312-315 (Pubitemid 23083808)
8. Benyamin RM, Vallejo R, Kramer J, Rafeyan R (2008) Corticosteroid induced psychosis in the pain management setting. Pain Phys 11:917-920
9. Cushing H (1932) Harvey lectures-dyspituitarism. Bull Johns Hopkins Hosp 50:137
10. Haskett RF (1985) Diagnostic categorization of psychiatric disturbance in Cushing's syndrome. Am J Psychiatry 142:911-916 (Pubitemid 15240231)
11. Sirois F (2003) Steroid psychosis: a review. Gen Hosp Psychiatry 25:27-33 (Pubitemid 36173782)
12. Wolkowitz OM, Burke H, Epel ES, Reus VI (2009) Glucocorticoids. Mood, memory, and mechanisms. Ann NY Acad Sci 1179:19-40
13. Clark LD, Bauer W, Cobb S (1952) Preliminary observations on mental disturbances occurring in patients under therapy with cortisone and ACTH. N Engl J Med 246:205-216
14. Glaser GH (1953) Psychotic reactions induced by corticotropin (ACTH) cortisone. Psychosom Med 15:280-291
15. The Boston Collaborative Drug Surveillance Program (1972) Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 13:694-698
16. Hall RC, Popkin MK, Stickney SK, Gardner ER (1979) Presentation of the steroid psychoses. J Nerv Ment Dis 167:229-236 (Pubitemid 9167954)
17. Keenan PA, Jacobson MW, Soleymani RM, Mayes MD, Stress ME, Yaldoo DT (1996) The effect on memory of chronic prednisone treatment in patients with systemic disease. Neurology 47:1396-1402 (Pubitemid 26422526)
18. Sacks O, Shulman M (2005) Steroid dementia: an overlooked diagnosis? Neurology 64:707-709 (Pubitemid 40261902)
19. Stiefel FC, Breitbart WS, Holland JC (1989) Corticosteroids in cancer: neuropsychiatric complications. Cancer Invest 7:479-491 (Pubitemid 20119596)
20. Brown ES, Chandler PA (2001) Mood and cognitive changes during systemic corticosteroid therapy. Prim Care Companion J Clin Psychiatry 3:17-21 (Pubitemid 33807485)
21. Wada K, Yamada N, Sato T, Suzuki H, Miki M, Lee Y, Akiyama K, Kuroda S (2001) Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures. Psychosomatics 42:461-466 (Pubitemid 34084246)
22. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington DC
23. Cohen SI (1980) Cushing's syndrome: a psychiatric study of 29 patients. Br J Psychiatry 136:120-124 (Pubitemid 10183245)
24. Starkman MN, Schteingart DE, Schork MA (1981) Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels. Psychosom Med 43:3-18 (Pubitemid 11136454)
25. Starkman MN, Schteingart DE, Schork MA (1986) Cushing's syndrome after treatment: changes in cortisol and ACTH levels, and amelioration of the depressive syndrome. Psychiatry Res 19:177-188 (Pubitemid 17171319)
26. Wolkowitz OM, Reus VI, Canick J, Levin B, Lupien S (1997) Glucocorticoid medication, memory and steroid psychosis in medical illness. Ann NY Acad Sci 823:81-96 (Pubitemid 27424889)
27. Forget H, Lacroix A, Cohen H (2002) Persistent cognitive impairment following surgical treatment of Cushing's syndrome. Psychoneuroendocrinology 27:367-383 (Pubitemid 34121979)
28. Heald AH, Ghosh S, Bray S, Gibson C, Anderson SG, Buckler H, Fowler HL (2004) Long-term negative impact on quality of life in patients with successfully treated Cushing's disease. Clin Endocrinol (Oxf) 61:458-465 (Pubitemid 39388484)
29. Merke DP, Giedd JN, Keil MF, Mehlinger SL, Wiggs EA, Holzer S, Rawson E, Vaituzis AC, Stratakis CA, Chrousos GP (2005) Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing syndrome. J Clin Endocrinol Metab 90:2531-2536 (Pubitemid 40686287)
30. Sonino N, Fava GA (2001) Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment. CNS Drugs 15:361-373 (Pubitemid 32487993)
31. Varney NR, Alexander B, MacIndoe JH (1984) Reversible steroid dementia in patients without steroid psychosis. Am J Psychiatry 141:369-372 (Pubitemid 14194837)
32. Suess WM, Stump N, Chai H, Kalisker A (1986) Mnemonic effects of asthma medication in children. J Asthma 23:291-296 (Pubitemid 17137344)
33. Hirsch D, Orr G, Kantarovich V, Hermesh H, Stern E, Blum I (2000) Cushing's syndrome presenting as a schizophrenia-like psychotic state. Isr J Psychiatry Relat Sci 37:46-50
34. Sonino N, Bonnini S, Fallo F, Boscaro M, Fava GA (2006) Personality characteristics and quality of life in patients treated for Cushing's syndrome. Clin Endocrinol (Oxf) 64:314-318
35. Patten SB, Neutel CI (2000) Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf 22:111-122 (Pubitemid 30072057)
36. Greeves JA (1984) Rapid-onset steroid psychosis with very low dosage of prednisolone. Lancet 1:1119-1120 (Pubitemid 14100822)
37. Baloch N (1974) 'Steroid psychosis': a case report. Br J Psychiatry 124:545-546
38. Robinson DE, Harrison-Hansley E, Spencer RF (2000) Steroid psychosis after an intra-articular injection. Ann Rheum Dis 59:927
39. Garner HH, Falk MA (1967) Toxic psychosis: pemphigus and psychiatric disease. Psychosomatics 8:133-137
40. Rome HP, Braceland FJ (1952) The psychological response to ACTH, cortisone, hydrocortisone, and related steroid substances. Am J Psychiatry 108:641-651
41. Brody S (1952) Psychiatric observations in patients treated with cortisone and ACTH. Psychosom Med 14:94-103
42. Lewis DA, Smith RE (1983) Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord 5:319-332 (Pubitemid 14244152)
43. Goggans FC, Weisberg LJ, Koran LM (1983) Lithium prophylaxis of prednisone psychosis: a case report. J Clin Psychiatry 44:111-112 (Pubitemid 13153393)
44. Wada K, Yamada N, Suzuki H, Lee Y, Kuroda S (2000) Recurrent cases of corticosteroid-induced mood disorder: clinical characteristics and treatment. J Clin Psychiatry 61:261-267 (Pubitemid 30305367)
45. Vincent FM (1995) The neuropsychiatric complications of corticosteroid therapy. Compr Ther 21:524-528
46. Cope CL (1953) Cortisone and A. C. T. H. BMJ 2:271-273
47. Evans RR, Rackemann FM (1952) Allergy; corticotropin and cortisone: a review of the literature from September, 1950, to January, 1952. AMA Arch Intern Med 90:96-127
48. Kershner P, Wang-Cheng R (1989) Psychiatric side effects of steroid therapy. Psychosomatics 30:135-139 (Pubitemid 19103444)
49. Lewis A, Fleminger JJ (1954) The psychiatric risk from corticotrophin and cortisone. Lancet 266:383-386
50. Sonin L, Patterson R (1984) Corticosteroid-dependent asthma and schizophrenia. Arch Intern Med 144:554-556 (Pubitemid 14152739)
51. Ling MH, Perry PJ, Tsuang MT (1981) Side effects of corticosteroid therapy. Psychiatric aspects. Arch Gen Psychiatry 38:471-477 (Pubitemid 11156032)
52. Zuloaga DG, Poort JE, Jordan CL, Breedlove SM (2011) Male rats with the testicular feminization mutation of the androgen receptor display elevated anxiety-related behavior and corticosterone response to mild stress. Horm Behav 60:380-388
53. Liston C, Gan WB (2011) Glucocorticoids are critical regulators of dendritic spine development and plasticity in vivo. Proc Natl Acad Sci USA 108:16074-16079
54. Saporito MS, Brown ER, Hartpence KC, Wilcox HM, Robbins E, Vaught JL, Carswell S (1994) Systemic dexamethasone administration increases septal Trk autophosphorylation in adult rats via an induction of nerve growth factor. Mol Pharmacol 45:395-401 (Pubitemid 24094927)
55. McEwen BS (1991) Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 12:141-147
56. Strous RD, Maayan R, Weizman A (2006) The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside. Eur Neuropsychopharmacol 16:155-169 (Pubitemid 43358006)
57. Mellon SH, Griffin LD (2002) Neurosteroids: biochemistry and clinical significance. Trends Endocrinol Metab 13:35-43 (Pubitemid 36734014)
58. Schumacher M, Akwa Y, Guennoun R, Robert F, Labombarda F, Desarnaud F, Robel P, De Nicola AF, Baulieu EE (2000) Steroid synthesis and metabolism in the nervous system: trophic and protective effects. J Neurocytol 29:307-326 (Pubitemid 32154515)
59. Rupprecht R, di Michele F, Hermann B, Strohle A, Lancel M, Romeo E, Holsboer F (2001) Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res Brain Res Rev 37:59-67 (Pubitemid 34020720)
60. McEwen BS (1987) Glucocorticoid-biogenic amine interactions in relation to mood and behavior. Biochem Pharmacol 36:1755-1763 (Pubitemid 17084454)
61. Wolkowitz OM, Epel ES, Reus VI (2001) Stress hormonerelated psychopathology: pathophysiological and treatment implications. World J Biol Psychiatry 2:115-143
62. Cardounel A, Regelson W, Kalimi M (1999) Dehydroepiandrosterone protects hippocampal neurons against neurotoxininduced cell death: mechanism of action. Proc Soc Exp Biol Med 222:145-149
63. Kimonides VG, Khatibi NH, Svendsen CN, Sofroniew MV, Herbert J (1998) Dehydroepiandrosterone (DHEA) and DHEAsulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci USA 95:1852-1857 (Pubitemid 28103483)
64. Maninger N, Wolkowitz OM, Reus VI, Epel ES, Mellon SH (2009) Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol 30:65-91
65. Giordano R, Di Vito L, Lanfranco F, Broglio F, Benso A, Gianotti L, Grottoli S, Ghigo E, Arvat E (2001) Elderly subjects show severe impairment of dehydroepiandrosterone sulphate and reduced sensitivity of cortisol and aldosterone response to the stimulatory effect of ACTH (1-24). Clin Endocrinol (Oxf) 55:259-265 (Pubitemid 32868593)
66. Schumacher M, Weill-Engerer S, Liere P, Robert F, Franklin RJ, Garcia-Segura LM, Lambert JJ, Mayo W, Melcangi RC, Parducz A, Suter U, Carelli C, Baulieu EE, Akwa Y (2003) Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog Neurobiol 71:3-29 (Pubitemid 37377932)
67. McEwen BS (1998) Protective and damaging effects of stress mediators. N Engl J Med 338:171-179
68. McEwen BS (2006) Protective and damaging effects of stress mediators: central role of the brain. Dialogues Clin Neurosci 8:367-381 (Pubitemid 46102239)
69. McEwen BS, Seeman T (1999) Protective and damaging effects of mediators of stress. Elaborating and testing the concepts of allostasis and allostatic load. Ann NY Acad Sci 896:30-47 (Pubitemid 30040236)
70. Sapolsky RM (1996) Stress, glucocorticoids, and damage to the nervous system: the current state of confusion. Stress 1:1-19
71. Sapolsky RM, Romero LM, Munck AU (2000) How do glucocorticoids influence stress responses? integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21:55-89 (Pubitemid 32266068)
72. McEwen BS (1997) Possible mechanisms for atrophy of the human hippocampus. Mol Psychiatry 2:255-262 (Pubitemid 27217691)
73. Sapolsky RM (2000) The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 48:755-765
74. Woolley CS, Gould E, McEwen BS (1990) Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res 531:225-231 (Pubitemid 20348626)
75. Starkman MN, Giordani B, Gebarski SS, Berent S, Schork MA, Schteingart DE (1999) Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease. Biol Psychiatry 46:1595-1602 (Pubitemid 30001601)
76. Sapolsky RM (1996) Why stress is bad for your brain. Science 273:749-750 (Pubitemid 26271508)
77. de Leon MJ, McRae T, Rusinek H, Convit A, De Santi S, Tarshish C, Golomb J, Volkow N, Daisley K, Orentreich N, McEwen B (1997) Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease. J Clin Endocrinol Metab 82:3251-3259 (Pubitemid 27419066)
78. McEwen BS (1997) The brain is an important target of adrenal steroid actions. A comparison of synthetic and natural steroids. Ann NY Acad Sci 823:201-213 (Pubitemid 27424900)
79. Sapolsky RM (1994) The physiological relevance of glucocorticoid endangerment of the hippocampus. Ann NY Acad Sci 746:294-304 (discussion 297-304)
80. Kirschbaum C, Wolf OT, May M, Wippich W, Hellhammer DH (1996) Stress-and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults. Life Sci 58:1475-1483 (Pubitemid 26122725)
81. Keenan PA, Kuhn TW (1999) Do glucocorticoids have adverse effects on brain function? CNS Drugs 11:245-251 (Pubitemid 29187539)
82. Schatzberg AF, Rothschild AJ, Langlais PJ, Bird ED, Cole JO (1985) A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatr Res 19:57-64 (Pubitemid 15133225)
83. De Kloet ER (1997) Why dexamethasone poorly penetrates in brain. Stress 2:13-20
84. Karssen AM, Meijer OC, Berry A, Sanjuan Pinol R, de Kloet ER (2005) Low doses of dexamethasone can produce a hypocorticosteroid state in the brain. Endocrinology 146:5587-5595 (Pubitemid 41653075)
85. Stuart FA, Segal TY, Keady S (2005) Adverse psychological effects of corticosteroids in children and adolescents. Arch Dis Child 90:500-506 (Pubitemid 40627447)
86. Rothschild AJ, Langlais PJ, Schatzberg AF, Miller MM, Saloman MS, Lerbinger JE, Cole JO, Bird ED (1985) The effects of a single acute dose of dexamethasone on monoamine and metabolite levels in rat brain. Life Sci 36:2491-2501 (Pubitemid 15072755)
87. Seeman P, Schwarz J, Chen JF, Szechtman H, Perreault M, McKnight GS, Roder JC, Quirion R, Boksa P, Srivastava LK, Yanai K, Weinshenker D, Sumiyoshi T (2006) Psychosis pathways converge via D2 high dopamine receptors. Synapse 60:319-346 (Pubitemid 44134353)
88. Reckart MD, Eisendrath SJ (1990) Exogenous corticosteroid effects on mood and cognition: case presentations. Int J Psychosom 37:57-61 (Pubitemid 20380400)
89. Braunig P, Bleistein J, Rao ML (1989) Suicidality and corticosteroidinduced psychosis. Biol Psychiatry 26:209-210
90. Venkatarangam SH, Kutcher SP, Notkin RM (1988) Secondary mania with steroid withdrawal. Can J Psychiatry 33:631-632 (Pubitemid 18259824)
91. Campbell KM, Schubert DS (1991) Delirium after cessation of glucocorticoid therapy. Gen Hosp Psychiatry 13:270-272
92. Blazer DG 2nd, Petrie WM, Wilson WP (1976) Affective psychoses following renal transplant. Dis Nerv Syst 37:663-667 (Pubitemid 8027492)
93. Brown ES, Khan DA, Nejtek VA (1999) The psychiatric side effects of corticosteroids. Ann Allergy Asthma Immunol 83:495-503 (quiz 494-503)
94. Falk WE, Mahnke MW, Poskanzer DC (1979) Lithium prophylaxis of corticotropin-induced psychosis. JAMA 241:1011-1012 (Pubitemid 9228186)
95. Siegal FP (1978) Lithium for steroid-induced psychosis. N Engl J Med 299:155-156 (Pubitemid 8394543)
96. Terao T, Yoshimura R, Shiratuchi T, Abe K (1997) Effects of lithium on steroid-induced depression. Biol Psychiatry 41:1225-1226 (Pubitemid 27237184)
97. Reus VI, Wolkowitz OM (1993) Behavioral side effects of corticosteroid therapy. Psychiatr Ann 23:703-708
98. Bloch M, Gur E, Shalev A (1994) Chlorpromazine prophylaxis of steroid-induced psychosis. Gen Hosp Psychiatry 16:42-44 (Pubitemid 24145247)
99. Abbas A, Styra R (1994) Valproate prophylaxis against steroid induced psychosis. Can J Psychiatry 39:188-189 (Pubitemid 24163723)
100. Himelhoch S, Haller E (1996) Extreme mood lability associated with systemic lupus erythematosus and stroke successfully treated with valproic acid. J Clin Psychopharmacol 16:469-470 (Pubitemid 26423321)
101. Kahn D, Stevenson E, Douglas CJ (1988) Effect of sodium valproate in three patients with organic brain syndromes. Am J Psychiatry 145:1010-1011
102. Goldman LS, Goveas J (2002) Olanzapine treatment of corticosteroidinduced mood disorders. Psychosomatics 43:495-497 (Pubitemid 35286058)
103. Hall RC, Popkin MK, Kirkpatrick B (1978) Tricyclic exacerbation of steroid psychosis. J Nerv Ment Dis 166:738-742 (Pubitemid 9079109)
104. Preda A, Fazeli A, McKay BG, Bowers MB Jr, Mazure CM (1999) Lamotrigine as prophylaxis against steroid-induced mania. J Clin Psychiatry 60:708-709 (Pubitemid 29503656)
105. Wyszynski AA, Wyszynski B (1993) Treatment of depression with fluoxetine in corticosteroid-dependent central nervous system Sjogren's syndrome. Psychosomatics 34:173-177 (Pubitemid 23094145)
106. Beshay H, Pumariega AJ (1998) Sertraline treatment of mood disorder associated with prednisone: a case report. J Child Adolesc Psychopharmacol 8:187-193 (Pubitemid 28550709)
107. Ros LT (2004) Symptomatic depression after long-term steroid treatment: a case report. Afr J Med Med Sci 33:263-265
108. Ismail M, Lyster G (2002) Treatment of psychotic depression associated with steroid therapy in Churg-Strauss syndrome. Ir Med J 95:18-19
109. Ahmad M, Rasul FM (1999) Steroid-induced psychosis treated with haloperidol in a patient with active chronic obstructive pulmonary disease. Am J Emerg Med 17:735
110. Ingram DG, Hagemann TM (2003) Promethazine treatment of steroid-induced psychosis in a child. Ann Pharmacother 37:1036-1039 (Pubitemid 36875236)
111. Silva RG, Tolstunov L (1995) Steroid-induced psychosis: report of case. J Oral Maxillofac Surg 53:183-186
112. Brown ES, Chamberlain W, Dhanani N, Paranjpe P, Carmody TJ, Sargeant M (2004) An open-label trial of olanzapine for corticosteroid-induced mood symptoms. J Affect Disord 83:277-281 (Pubitemid 39536206)
113. DeSilva CC, Nurse MC, Vokey K (2002) Steroid-induced psychosis treated with risperidone. Can J Psychiatry 47:388-389
114. Kramer TM, Cottingham EM (1999) Risperidone in the treatment of steroid-induced psychosis. J Child Adolesc Psychopharmacol 9:315-316
115. Saklad SR (1987) Management of corticosteroid-induced psychosis with lithium. Clin Pharm 6:186 (Pubitemid 17047226)
116. Chiu CT, Chuang DM (2011) Neuroprotective action of lithium in disorders of the central nervous system. Zhong Nan Da Xue Xue Bao Yi Xue Ban 36:461-476
117. Beurel E, Michalek SM, Jope RS (2010) Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol 31:24-31
118. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH, Manji HK (1999) The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 72:879-882 (Pubitemid 29055256)
119. Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S (2001) Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) 158:100-106
120. Hashimoto R, Senatorov V, Kanai H, Leeds P, Chuang DM (2003) Lithium stimulates progenitor proliferation in cultured brain neurons. Neuroscience 117:55-61 (Pubitemid 36246503)
121. Maayan R, Shaltiel G, Poyurovsky M, Ramadan E, Morad O, Nechmad A, Weizman A, Agam G (2004) Chronic lithium treatment affects rat brain and serum dehydroepiandrosterone (DHEA) and DHEA-sulphate (DHEA-S) levels. Int J Neuropsychopharmacol 7:71-75 (Pubitemid 38523810)
122. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK (2000) Lithium-induced increase in human brain grey matter. Lancet 356:1241-1242
123. Moore GJ, Bebchuk JM, Hasanat K, Chen G, Seraji-Bozorgzad N, Wilds IB, Faulk MW, Koch S, Glitz DA, Jolkovsky L, Manji HK (2000) Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry 48:1-8 (Pubitemid 30407144)
124. Malinow KL, Dorsch C (1984) Tricyclic precipitation of steroid psychosis. Psychiatr Med 2:351-354
125. Perényi A, Frecska E, Badgy G, Barcs G (1988) Panic attacks as a consequence of chronic corticosteroid therapy? Eur J Psychiatry 2:69-74
126. Davis JM, Leach A, Merk B, Janicak PG (1992) Treatment of steroid psychoses. Psychiatr Ann 22:487-491
127. Ularntinon S, Tzuang D, Dahl G, Shaw RJ (2010) Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone. Pediatrics 125:e1241-e1245
128. Gardner DM, Baldessarini RJ, Waraich P (2005) Modern antipsychotic drugs: a critical overview. CMAJ 172:1703-1711 (Pubitemid 40896865)
129. Kapur S, Seeman P (2001) Does fast dissociation from the dopamine d (2) receptor explain the action of atypical antipsychotics?: a new hypothesis. Am J Psychiatry 158:360-369 (Pubitemid 32205190)
130. Wolkowitz OM, Reus VI (1999) Treatment of depression with antiglucocorticoid drugs. Psychosom Med 61:698-711 (Pubitemid 29455090)
131. Gallagher P, Malik N, Newham J, Young AH, Ferrier IN, Mackin P (2008) Antiglucocorticoid treatments for mood disorders. Cochrane Database Syst Rev: CD005168
132. Thakore JH, Dinan TG (1995) Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression. Biol Psychiatry 37:364-368
133. Checkley SA, O'Dwyer AM, Raven P, Taylor N, Lightman S (1994) Antidepressant effects of treatments with metyrapone and hydrocortisone. Biol Psychiatry 35:711